{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:58:46Z","timestamp":1781848726343,"version":"3.54.5"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Objective:<\/jats:bold> Antiangiogenic therapies (tyrosine kinase inhibitors-TKI and direct anti-VEGF monoclonal antibodies) are being increasingly used in the treatment of solid tumors; hypertension represents a common side effect of these agents. Several mechanisms are involved in the development of hypertension, including microvascular rarefaction and other microvascular alterations. Therefore, the aim of our study was to evaluate whether TKI and direct anti-VEGF agents may affect the structure of retinal arterioles or capillary density.<\/jats:p><jats:p><jats:bold>Design and Methods:<\/jats:bold> We investigated 20 patients with a diagnosis of cancer who underwent a treatment with either a TKI or an anti-VEGF antibody. Patients were submitted to ambulatory monitoring blood pressure for blood pressure evaluation. Basal and total capillary density were assessed by capillaroscopy whereas, retinal arteriole morphology was measured by Adaptive Optics. Patients were evaluated before starting the antiangiogenic therapy (T0) and re-evaluated after 3 (T3) and 6 (T6) months after treatment. Fourteen patients completed the study.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Systolic and diastolic blood pressure values were similar in all patients at T3 and T6 compared to T0. However, during the study antihypertensive treatment was optimized (increased dose and\/or addition of drugs) in 57% of patients (<jats:italic>n<\/jats:italic> = 8). No differences were observed in retinal arteriole structural parameters and in large artery stiffness. Basal capillary density was reduced by antiangiogenic drugs after 3 or 6 months.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our data suggest that an increase of antihypertensive treatment is necessary in patients treated with a TKI or a direct VEGF inhibitor, confirming pro-hypertensive effects of these drugs. However, under adequate blood pressure control, microvascular structure seem to be partially preserved, since a worsening of basal capillary density but no changes in retinal arteriole morphology were observed.<\/jats:p>","DOI":"10.3389\/fcvm.2021.651594","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T04:27:23Z","timestamp":1615350443000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs"],"prefix":"10.3389","volume":"8","author":[{"given":"Maria Antonietta","family":"Coschignano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"De Ciuceis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Agabiti-Rosei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Brami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Rossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Chiarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Malerba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Fam\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorenza","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Petelca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Capellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Arnoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Nardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Rizzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0093-7754(02)70065-1","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3322\/caac.21235","article-title":"Treatment and survivorship statistics","volume":"64","author":"De Santis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nrc2505","article-title":"VEGF-A splicing: the key to anti-angiogenic therapeutics?","volume":"8","author":"Harper","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1248\/bpb.34.1785","article-title":"Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy","volume":"34","author":"Takahashi","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"B7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"B8","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1634\/theoncologist.11-7-753","article-title":"Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions","volume":"11","author":"Morabito","year":"2006","journal-title":"Oncologist"},{"key":"B9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40292-017-0198-z","article-title":"Use of antihypertensive drugs in neoplastic patients","volume":"24","author":"Rizzoni","year":"2017","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s11906-018-0871-1","article-title":"Management of VEGF-targeted therapy-induced hypertension","volume":"20","author":"Caletti","year":"2018","journal-title":"Cur Hypertens Rep"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/annonc\/mdm184","article-title":"Hypertension as a predictive factor of sunitinib activity","volume":"18","author":"Rixe","year":"2007","journal-title":"Ann Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.18632\/oncotarget.24635","article-title":"Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel","volume":"9","author":"Fukuda","year":"2018","journal-title":"Oncotarget"},{"key":"B13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1634\/theoncologist.2012-0339","article-title":"Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies","volume":"18","author":"Hurwitz","year":"2013","journal-title":"Oncologist"},{"key":"B14","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1152\/physrev.1982.62.2.347","article-title":"Physiological aspects of primary hypertension","volume":"62","author":"Folkow","year":"1982","journal-title":"Physiol Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1152\/physrev.1990.70.4.921","article-title":"Structure and function of small arteries","volume":"70","author":"Mulvany","year":"1990","journal-title":"Physiol Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1097\/HJH.0000000000001259","article-title":"Microvascular structure as a prognostically relevant endpoint","volume":"35","author":"Agabiti-Rosei","year":"2017","journal-title":"J Hypertens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1097\/HJH.0000000000000322","article-title":"Evaluation of microvascular structure in humans: a 'state-of-the-art' document of the Working Group on Macrovascular and Microvascular Alterations of the Italian Society of Arterial Hypertension","volume":"32","author":"Virdis","year":"2014","journal-title":"J Hypertens"},{"key":"B18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/ajh\/hpx211","article-title":"New methods to study the microcirculation","volume":"31","author":"Rizzoni","year":"2018","journal-title":"Am J Hypertens"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/annonc\/mdp417","article-title":"Reversibility of capillary density after discontinuation of bevacizumab treatment","volume":"21","author":"Steeghs","year":"2010","journal-title":"Ann Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/cancers11010030","article-title":"Effects of antiangiogenetic drugs on microcirculation and macrocirculation in patients with advanced-stage renal cancer","volume":"11","author":"Dalbeni","year":"2018","journal-title":"Cancers (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/0151642-200815040-00008","article-title":"Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours","volume":"15","author":"Parati","year":"2008","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/echo.12855","article-title":"European Society of Hypertension Working Group on blood pressure monitoring and cardiovascular variability. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring","volume":"32","author":"Parati","year":"2014","journal-title":"J Hypertens"},{"key":"B23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/MBP.0b013e328339be38","article-title":"Evaluation of the Mobil-O-Graph new generation ABPM device using the ESH criteria","volume":"15","author":"Franssen","year":"2010","journal-title":"Blood Press Monit"},{"key":"B24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/jhh.2016.11","article-title":"A comparison study of brachial blood pressure recorded with Spacelabs 90217A and Mobil-O-Graph NG devices under static and ambulatory conditions","volume":"30","author":"Sarafidis","year":"2016","journal-title":"J Hum Hypertens"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002690","article-title":"Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial","author":"Papadopoulou","year":"2020","journal-title":"J Hypertens"},{"key":"B26","doi-asserted-by":"publisher","first-page":"630","DOI":"10.2215\/CJN.08180814","article-title":"Ambulatory recording of wave reflections and arterial stiffness during intra- and interdialytic periods in patients treated with dialysis","volume":"10","author":"Karpetas","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1161\/HYPERTENSIONAHA.111.176313","article-title":"Validation of a brachial cuff-based method for estimating central systolic blood pressure","volume":"58","author":"Weber","year":"2011","journal-title":"Hypertension"},{"key":"B28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/MBP.0b013e3283614168","article-title":"Oscillometric estimation of aortic pulse wave velocity: comparison with intra-aortic catheter measurements","volume":"18","author":"Hametner","year":"2013","journal-title":"Blood Press Monit"},{"key":"B29","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/hr.2012.78","article-title":"24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study","volume":"35","author":"Luzardo","year":"2012","journal-title":"Hypertens Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/HJH.0000000000001677","article-title":"Comparison between invasive and noninvasive techniques of evaluation of microvascular structural alterations","volume":"36","author":"De Ciuceis","year":"2018","journal-title":"J Hypertens"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1097\/00004872-199816120-00014","article-title":"Structural association between the carotid artery and the left ventricle in a general population in Northern Italy: the Vobarno study","volume":"16","author":"Muiesan","year":"1998","journal-title":"J Hypertens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/annonc\/mdm550","article-title":"Blood pressure rise following angiogenesis inhibition by bevacizumab: a crucial role for microcirculation","volume":"19","author":"Mourad","year":"2008","journal-title":"Ann Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1158\/1078-0432.CCR-07-5050","article-title":"Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor","volume":"14","author":"Steeghs","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/08037051.2012.749584","article-title":"Circulating endothelial progenitor cells, microvascular density and fibrosis in obesity before and after bariatric surgery","volume":"22","author":"De Ciuceis","year":"2013","journal-title":"Blood Press"},{"key":"B35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/HJH.0000000000000067","article-title":"Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension","volume":"32","author":"De Ciuceis","year":"2014","journal-title":"J Hypertens"},{"key":"B36","doi-asserted-by":"publisher","first-page":"ehaa857","DOI":"10.1093\/eurheartj\/ehaa857","article-title":"Assessment and pathophysiology of microvascular disease: recent progress and clinical implications","author":"Masi","year":"2020","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00004872-200303000-00030","article-title":"Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients","volume":"21","author":"Rizzoni","year":"2003","journal-title":"J Hypertens"},{"key":"B38","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/HJH.0b013e32832401ea","article-title":"Altered structure of small cerebral arteries in patients with essential hypertension","volume":"27","author":"Rizzoni","year":"2009","journal-title":"J Hypertens"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1042\/CS20200308","article-title":"Vascular toxicity associated with anti-angiogenic drugs","volume":"134","author":"Neves","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"B40","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1097\/HJH.0000000000000095","article-title":"Morphometric analysis of small arteries in the human retina using adaptive optics imaging: relationship with blood pressure and focal vascular changes","volume":"32","author":"Koch","year":"2014","journal-title":"J Hypertens"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"B42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jash.2018.03.008","article-title":"Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events","volume":"12","author":"Touyz","year":"2018","journal-title":"J Am Soc Hypertens"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.651594\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T04:27:26Z","timestamp":1615350446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.651594\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":42,"alternative-id":["10.3389\/fcvm.2021.651594"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.651594","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"article-number":"651594"}}